market-trends is the sole category represented across all 2 tracked stories. AstraZeneca Plc is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 118-day span.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Fisher Asset Management LLC
market-trends is the sole category represented across all 2 tracked stories. AstraZeneca Plc is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 118-day span. They are less corroborated than the beat average, carrying 2 original sources each against 3.5 for the same window. The 5 average consequence score is below the beat benchmark of 6 in the same window. We currently track 2 Healthcare stories that mention Fisher Asset Management LLC, published between March 3, 2026 and June 28, 2026.
Stories tracked
2
Per week
0.1
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 578 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Fisher Asset Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Six major institutional investors have collectively added over 3.8 million AstraZeneca shares across recent quarters, signaling strong professional confidence in the company's diversified healthcare portfolio spanning oncology, cardiovascular, respiratory, and rare disease treatments. The sustained buying pattern highlights institutional conviction in AstraZeneca's ability to deliver innovative therapies that address critical unmet medical needs.
Fisher Asset Management LLC increased its position in Eli Lilly and Company by 3.5% during the third quarter, acquiring an additional 150,595 shares. The move brings the firm's total holdings to over 4.45 million shares, signaling continued institutional confidence in the pharmaceutical giant's growth trajectory.
Fisher Asset Management LLC is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
